Modified Edmonton Symptom Assessment System including constipation and sleep: validation in outpatients with cancer.

@article{Hannon2015ModifiedES,
  title={Modified Edmonton Symptom Assessment System including constipation and sleep: validation in outpatients with cancer.},
  author={Breffni Hannon and Maarten Van Dyck and Ashley Pope and Nadia Swami and Subrata Chattopadhyay Banerjee and Ernie Mak and John Bryson and Gary M Rodin and Julia Ridley and Christopher Lo and Lisa W. Le and Camilla Zimmermann},
  journal={Journal of pain and symptom management},
  year={2015},
  volume={49 5},
  pages={
          945-52
        }
}
CONTEXT The Edmonton Symptom Assessment System (ESAS) measures the severity of nine symptoms. Constipation and sleep disturbance are common in patients with cancer, but are not currently included in the ESAS. OBJECTIVES To validate the numerical rating scale (NRS) versions of ESAS and its revised version (ESAS-r), with the additional symptoms of constipation and sleep (CS), and to assess patient preference for either version. METHODS Outpatients with advanced cancer (N = 202) completed… Expand
Screening for clinical insomnia in cancer patients with the Edmonton Symptom Assessment System-Revised: a specific sleep item is needed
TLDR
Adding a sleep item to the ESAS significantly improves screening of clinical insomnia in cancer patients. Expand
Capacity of the Edmonton Symptom Assessment System and the Canadian Problem Checklist to screen clinical insomnia in cancer patients
TLDR
When used alone, the CPC-sleep and the ESAS-drowsiness items yielded insufficient sensitivity rates for a first screening, but when used in combination, they provided a good balance between sensitivity and specificity. Expand
Symptom screening for constipation in oncology: getting to the bottom of the matter
TLDR
Care pathways should include guidance on triaging results from multi-symptom screening, and clinicians should pay particular attention to patients who are missed from screening altogether, as they may be the most symptomatic group. Expand
The Edmonton Symptom Assessment Scale remains useful for depression screening
TLDR
Remarkably, Brenne and colleagues reported high specificity (>90%) for major depression with ESAS– depression cutoffs of 6 or greater, highlighting the utility of this tool to support the diagnosis of major depression. Expand
The Edmonton Symptom Assessment System 25 Years Later: Past, Present, and Future Developments.
TLDR
ESAS has evolved over the past 25 years to become an important symptom assessment instrument in both clinical practice and research and future efforts are needed to standardize this tool and explore its full potential to support symptom management. Expand
The Edmonton Symptom Assessment System: A narrative review of a standardized symptom assessment tool in head and neck oncology.
OBJECTIVE Symptom burden is common in head and neck cancer patients though it frequently remains undetected and untreated. The Edmonton Symptom Assessment System - revised version (ESAS-r) is aExpand
An Evaluation of the Psychometric Properties of the Edmonton Symptom Assessment System in a New Zealand Community Hospice Setting
TLDR
The ESAS is shown to have some evidence of validity and reliability for assessing symptoms within the present research setting of New Zealand, community palliative care, however, the present study identified inconsistent factor structures. Expand
Transcultural Validation of the French Version of the Modified Edmonton Symptom Assessment Scale: The ESAS12-F.
TLDR
A translation and cross-cultural validation in French of the modified 12-item ESAS-r, the ESAS12-F is well accepted and easy to use for the cancer patients. Expand
Symptom Assessment in Patients with Advanced Cancer: Are the Most Severe Symptoms the Most Bothersome?
TLDR
Investigation of correspondence between symptom severity and symptom bothersomeness in patients with advanced cancer found pain and/or tiredness were consistently among the top three most bothersome ESAS symptoms, whereas appetite was frequently rated the most severe symptom but was rarely perceived as the most botherssome. Expand
mMRC dyspnoea scale indicates impaired quality of life and increased pain in patients with idiopathic pulmonary fibrosis
TLDR
Investigating idiopathic pulmonary fibrosis patients' health-related quality of life (HRQoL) and symptoms in a real-life cross-sectional study and studying the relationship between modified Medical Research Council dyspnoea scale, HRZoL and symptoms created a simple identification method for patients with increased need for palliative care. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 39 REFERENCES
Validation of the Edmonton Symptom Assessment System in Korean patients with cancer.
TLDR
The K-ESAS is a valid and reliable tool for measuring multidimensional symptoms in Korean patients with cancer and has good internal consistency, test-retest reliability, and concurrent validity. Expand
A multicenter study comparing two numerical versions of the Edmonton Symptom Assessment System in palliative care patients.
TLDR
The ESAS-r retains core elements of the ESAS, with improved interpretation and clarity of symptom intensity assessment, and represents the next generation of ESAS development, with further validation recommended for drowsiness, appetite, and well-being. Expand
A comprehensive study of psychometric properties of the Edmonton Symptom Assessment System (ESAS) in Spanish advanced cancer patients.
TLDR
ESAS is a valid, reliable, responsive and feasible instrument with adequate psychometric properties when tested on Spanish advanced cancer patients. Expand
The Edmonton Symptom Assessment System (ESAS): A Simple Method for the Assessment of Palliative Care Patients
TLDR
It is concluded that this is a simple and useful method for the regular assessment of symptom distress in the palliative care setting. Expand
Edmonton symptom assessment scale: Italian validation in two palliative care settings
TLDR
ESAS can be considered a valid, reliable and feasible instrument for physical symptom assessment in routine “palliative care” clinical practice with a potentially different responsiveness in different situations or care settings. Expand
The Edmonton symptom assessment system—what do patients think?
TLDR
Examination of patients’ cognitive processes while completing the ESAS revealed a need to emphasize the timeframe as “now”, and further study in other populations is needed. Expand
The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress.
TLDR
High correlations with clinical status and quality of life measures support the validity of the MSAS and indicate the utility of several subscale scores, including PSYCH, PHYS, and a brief Global Distress Index. Expand
The Edmonton Symptom Assessment System as a screening tool for depression and anxiety.
TLDR
The data suggest that the ideal cutoff point of ESAS for the screening of depression and anxiety in palliative care is 2 out of 10 or more, and more research is needed to define the ideal cut-off point for screening of severe depression and Anxiety. Expand
Self-reported sleep disturbance in patients with advanced cancer: Frequency, intensity, and factors associated with response to outpatient supportive care consultation — A preliminary report
TLDR
The severity of SD and anxiety at the initial visit predicted a response at first follow-up, and the frequency and severity ofSD were high, and response to supportive care consultation was substantial. Expand
Cross-sectional validity of a modified Edmonton symptom assessment system in dialysis patients: a simple assessment of symptom burden.
TLDR
The modified Edmonton Symptom Assessment System (ESAS) is a reliable, valid, simple, and useful method for regular symptom assessment in this patient population of dialysis patients. Expand
...
1
2
3
4
...